USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Integrated and Scalable Core Lab Solutions Driving Transformational Growth
30-Oct-2024
Global
Market Research
PFPY-01-00-00-00
HC_2024_1106
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health.
While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables. Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value.
Author: Amartya Bose
Scope of Analysis
Segmentation
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Clinical Chemistry and Immunoassay Industry
Competitive Environment
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Forecast Considerations
Revenue Forecast
Revenue Forecast by Application Areas
Revenue Forecast by Region
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity 1: Sepsis IVDs
Growth Opportunity 1: Sepsis IVDs (continued)
Growth Opportunity 2: Neurology IVDs
Growth Opportunity 2: Neurology IVDs (continued)
Growth Opportunity 3: Routine Testing
Growth Opportunity 3: Routine Testing (continued)
Growth Opportunity 4: Integrated Analyzers
Growth Opportunity 4: Integrated Analyzers (continued)
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Clinical Chemistry and Immunoassay: Growth Metrics, Global, 2023‒2028
- Clinical Chemistry and Immunoassay: Growth Drivers, Global, 2024-2028
- Clinical Chemistry and Immunoassay: Growth Restraints, Global, 2024-2028
- Clinical Chemistry and Immunoassay: Revenue Forecast, Global, 2023‒2028
- Clinical Chemistry and Immunoassay: Revenue Forecast by Application Areas, Global, 2023-2028
- Clinical Chemistry and Immunoassay: Revenue Forecast by Region, 2023-2028
- Clinical Chemistry and Immunoassay: Revenue Share of Top Participants, Global, 2023
- Cancer: Growth Metrics, Global, 2023
- Cancer: Revenue Forecast, Global, 2023-2028
- Cancer: Revenue Forecast by Region, 2023-2028
- Cardiac: Growth Metrics, Global, 2023
- Cardiac: Revenue Forecast, Global, 2023-2028
- Cardiac: Revenue Forecast by Region, 2023-2028
- Diabetes: Growth Metrics, Global, 2023
- Diabetes: Revenue Forecast, Global, 2023-2028
- Diabetes: Revenue Forecast by Region, 2023-2028
- Infectious Diseases: Growth Metrics, Global, 2023-2028
- Infectious Diseases: Revenue Forecast, Global, 2023-2028
- Infectious Diseases: Revenue Forecast by Region, 2023-2028
- Others: Growth Metrics, Global, 2023-2028
- Others: Revenue Forecast, Global, 2023-2028
- Others: Revenue Forecast by Region, 2023-2028
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Amartya Bose |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Clinical Chemistry Market |
| Keyword 2 | Global Diagnostics Growth |
| Keyword 3 | Healthcare Technologies |
| List of Charts and Figures | Clinical Chemistry and Immunoassay: Growth Metrics, Global, 2023‒2028~ Clinical Chemistry and Immunoassay: Growth Drivers, Global, 2024-2028~ Clinical Chemistry and Immunoassay: Growth Restraints, Global, 2024-2028~ Clinical Chemistry and Immunoassay: Revenue Forecast, Global, 2023‒2028~ Clinical Chemistry and Immunoassay: Revenue Forecast by Application Areas, Global, 2023-2028~ Clinical Chemistry and Immunoassay: Revenue Forecast by Region, 2023-2028~ Clinical Chemistry and Immunoassay: Revenue Share of Top Participants, Global, 2023~ Cancer: Growth Metrics, Global, 2023~ Cancer: Revenue Forecast, Global, 2023-2028~ Cancer: Revenue Forecast by Region, 2023-2028~ Cardiac: Growth Metrics, Global, 2023~ Cardiac: Revenue Forecast, Global, 2023-2028~ Cardiac: Revenue Forecast by Region, 2023-2028~ Diabetes: Growth Metrics, Global, 2023~ Diabetes: Revenue Forecast, Global, 2023-2028~ Diabetes: Revenue Forecast by Region, 2023-2028~ Infectious Diseases: Growth Metrics, Global, 2023-2028~ Infectious Diseases: Revenue Forecast, Global, 2023-2028~ Infectious Diseases: Revenue Forecast by Region, 2023-2028~ Others: Growth Metrics, Global, 2023-2028~ Others: Revenue Forecast, Global, 2023-2028~ Others: Revenue Forecast by Region, 2023-2028~ |
| Podcast | No |
| WIP Number | PFPY-01-00-00-00 |
Clinical Chemistry and Immunoassay Industry, Global, 2023?2028
$4,950.00
Special Price $4,207.50 save 15 %